Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1124864
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1124864
Cystic Fibrosis Market Share, Size, Trends, Industry Analysis Report, By Drug Class (CFTR Modulators, Mucolytics, Bronchodilators, Pancreatic Enzyme Supplements), Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030
PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Cystic Fibrosis Market size is expected to reach USD 37.04 billion by 2030, according to a new study by 24.3% Market Research. The report "Cystic Fibrosis Market Share, Size, Trends, Industry Analysis Report, By Drug Class (CFTR Modulators, Mucolytics, Bronchodilators, Pancreatic Enzyme Supplements), Route of Administration {Oral Drugs, Inhaled drugs}, By Distribution Channel, By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Rising awareness about cystic fibrosis and growing adoption of drug therapies are the prominent factors driving the cystic fibrosis market growth. A variety of oral and inhaled drugs are available for the treatment that increases compliance to the treatment owing to the ease and convenience of administering it. The widespread availability of different cystic fibrosis treatment options will expand the market size over the coming years.
Cystic fibrosis is a genetic disorder that affects more than 30,000 people in the U.S. and over 70,000 people are suffering from it worldwide. Additionally, more than approximately 1000 new cases of the disease are diagnosed every year.
Favorable technological advancements in this therapeutic area will open new avenues of growth for industry participants. Rising innovation in the development of new therapies and drug products to cure cystic fibrosis is anticipated to foster growth in the cystic fibrosis market over the analysis period.
Rising number of cases of respiratory illness post Covid-19 pandemic has spurred the cystic fibrosis market growth. It has given the key industry players an opportunity to focus on the development of new drugs that can enable fast recovery and reduce mortality rates across the globe.
High cost of treatment, stringent regulations prolong approval of drugs, and adverse effects of currently available drugs such as liver problems, upper respiratory tract infection, chest pain, and increased blood pressure among others will hinder the future market growth.
Cystic Fibrosis Market Report Highlights
CFTR modulators segment is anticipated to grow at a significant CAGR over the forecast period owing to their efficacy in improving body function at the cellular level and positively impact the quality of life.
Oral drugs accounted for a significant share owing to the preference among patients and medical practitioners due to the ease and convenience associated with administering the cystic fibrosis drugs
Hospital segment is expected to hold a significant market share among the distribution channels over the forecast period owing to the rising need for precise diagnosis and required medical supervision associated with the treatment. Moreover, the rising number of patient hospital visits will fuel the hospital segment growth.
North America is expected to grow at a significant CAGR over the projected period on account of the increasing incidence of cystic fibrosis and the availability of multiple treatment options in the region.
Global players include Vertex Pharmaceutical, Genentech Inc., Teva Pharmaceuticals, Gilead Sciences, Roche, Nestle Health Science, AbbVie, Vitric Inc., Novartis AG, Mylan N.V, Pfizer Inc., Bayer, AstraZeneca, and Horizon Therapeutic, among others.
Polaris Market Research has segmented the cystic fibrosis market report based on drug class, route of administration, distribution channel, and region:
Cystic Fibrosis Market, By Drug Class (Revenue - USD Billion, 2018 - 2030)
CFTR modulators
Mucolytics
Bronchodilators
Pancreatic enzyme supplements
Others
Cystic Fibrosis Market, By Route of Administration (Revenue - USD Billion, 2018 - 2030)
Oral drugs
Parenteral drugs
Cystic Fibrosis Market, By Distribution Channel (Revenue - USD Billion, 2018 - 2030)
Hospital
Retail pharmacies
Others
Cystic Fibrosis Market, By Region (Revenue - USD Billion, 2018 - 2030)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Product Code: PM1325
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Cystic Fibrosis Market Insights
- 4.1. Cystic Fibrosis - Industry Snapshot
- 4.2. Cystic Fibrosis Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rise in incidence of cystic fibrosis (CF)
- 4.2.1.2. Advancements in therapeutics for the treatment of cystic fibrosis
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Low awareness in developing nations
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Cystic Fibrosis Market Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Cystic Fibrosis Market, by Drug Class
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 5.3. CFTR modulators
- 5.3.1. Global Cystic Fibrosis Market, by CFTR modulators, by Region, 2018 - 2030 (USD Billion)
- 5.4. Mucolytics
- 5.4.1. Global Cystic Fibrosis Market, by Mucolytics, by Region, 2018 - 2030 (USD Billion)
- 5.5. Bronchodilators
- 5.5.1. Global Cystic Fibrosis Market, by Bronchodilators, by Region, 2018 - 2030 (USD Billion)
- 5.6. Pancreatic enzyme supplements
- 5.6.1. Global Cystic Fibrosis Market, by Pancreatic enzyme supplements, by Region, 2018 - 2030 (USD Billion)
- 5.7. Others
- 5.7.1. Global Other Cystic Fibrosis Market, by Region, 2018 - 2030 (USD Billion)
6. Global Cystic Fibrosis Market, by Route of Administration
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 6.3. Oral drugs
- 6.3.1. Global Cystic Fibrosis Market, by Oral drugs, by Region, 2018 - 2030 (USD Billion)
- 6.4. Parenteral drugs
- 6.4.1. Global Cystic Fibrosis Market, by Parenteral drugs, by Region, 2018 - 2030 (USD Billion)
7. Global Cystic Fibrosis Market, by Distribution channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 7.3. Hospital
- 7.3.1. Global Cystic Fibrosis Market, by Hospital, by Region, 2018 - 2030 (USD Billion)
- 7.4. Retail pharmacies
- 7.4.1. Global Cystic Fibrosis Market, by Retail pharmacies, by Region, 2018 - 2030 (USD Billion)
- 7.5. Others
- 7.5.1. Global Other Cystic Fibrosis Market, by Region, 2018 - 2030 (USD Billion)
8. Global Cystic Fibrosis Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Cystic Fibrosis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 8.3. Cystic Fibrosis Market - North America
- 8.3.1. North America: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.3.2. North America: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.3.3. North America: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.3.4. Cystic Fibrosis Market - U.S.
- 8.3.4.1. U.S.: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.3.4.2. U.S.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.3.4.3. U.S.: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.3.5. Cystic Fibrosis Market - Canada
- 8.3.5.1. Canada: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.3.5.2. Canada.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.3.5.3. Canada: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.4. Cystic Fibrosis Market - Europe
- 8.4.1. Europe: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.4.2. Europe.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.4.3. Europe: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.4.4. Cystic Fibrosis Market - UK
- 8.4.4.1. UK: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.4.4.2. UK.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.4.4.3. UK: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.4.5. Cystic Fibrosis Market - France
- 8.4.5.1. France: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.4.5.2. France.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.4.5.3. France: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.4.6. Cystic Fibrosis Market - Germany
- 8.4.6.1. Germany: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.4.6.2. Germany.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.4.6.3. Germany: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.4.7. Cystic Fibrosis Market - Italy
- 8.4.7.1. Italy: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.4.7.2. Italy.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.4.7.3. Italy: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.4.8. Cystic Fibrosis Market - Spain
- 8.4.8.1. Spain: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.4.8.2. Spain.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.4.8.3. Spain: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.4.9. Cystic Fibrosis Market - Netherlands
- 8.4.9.1. Netherlands: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.4.9.2. Netherlands.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.4.9.3. Netherlands: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.4.10. Cystic Fibrosis Market - Russia
- 8.4.10.1. Russia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.4.10.2. Russia.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.4.10.3. Russia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.5. Cystic Fibrosis Market - Asia Pacific
- 8.5.1. Asia Pacific: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.5.2. Asia Pacific.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.5.3. Asia Pacific: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.5.4. Cystic Fibrosis Market - China
- 8.5.4.1. China: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.5.4.2. China.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.5.4.3. China: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.5.5. Cystic Fibrosis Market - India
- 8.5.5.1. India: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.5.5.2. India.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.5.5.3. India: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.5.6. Cystic Fibrosis Market - Malaysia
- 8.5.6.1. Malaysia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.5.6.2. Malaysia.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.5.6.3. Malaysia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.5.7. Cystic Fibrosis Market - Japan
- 8.5.7.1. Japan: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.5.7.2. Japan.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.5.7.3. Japan: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.5.8. Cystic Fibrosis Market - Indonesia
- 8.5.8.1. Indonesia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.5.8.2. Indonesia.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.5.8.3. Indonesia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.5.9. Cystic Fibrosis Market - South Korea
- 8.5.9.1. South Korea: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.5.9.2. South Korea.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.5.9.3. South Korea: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.6. Cystic Fibrosis Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.6.2. Middle East & Africa.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.6.3. Middle East & Africa: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.6.4. Cystic Fibrosis Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.6.4.3. Saudi Arabia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.6.5. Cystic Fibrosis Market - UAE
- 8.6.5.1. UAE: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.6.5.2. UAE.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.6.5.3. UAE: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.6.6. Cystic Fibrosis Market - Israel
- 8.6.6.1. Israel: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.6.6.2. Israel.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.6.6.3. Israel: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.6.7. Cystic Fibrosis Market - South Africa
- 8.6.7.1. South Africa: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.6.7.2. South Africa.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.6.7.3. South Africa: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.7. Cystic Fibrosis Market - Latin America
- 8.7.1. Latin America: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.7.2. Latin America.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.7.3. Latin America: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.7.4. Cystic Fibrosis Market - Mexico
- 8.7.4.1. Mexico: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.7.4.2. Mexico.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.7.4.3. Mexico: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.7.5. Cystic Fibrosis Market - Brazil
- 8.7.5.1. Brazil: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.7.5.2. Brazil.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.7.5.3. Brazil: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 8.7.6. Cystic Fibrosis Market - Argentina
- 8.7.6.1. Argentina: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- 8.7.6.2. Argentina.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- 8.7.6.3. Argentina: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Vertex Pharmaceutical Incorporated
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Teva Pharmaceuticals
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. AbbVie
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Viatris Inc
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Genentech Inc
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Novartis AG
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Mylan N.V
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Pfizer Inc
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. BayerAG
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Astrazeneca
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Gilead Sciences
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Nestle Health Science
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Chiesi Farmacrutici
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Roche
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Pharmaxis Ltd
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
- 10.16. Horizon Therapeutic Plc
- 10.16.1. Company Overview
- 10.16.2. Financial Performance
- 10.16.3. Product Benchmarking
- 10.16.4. Recent Development
Product Code: PM1325
List of Tables
- Table 1 Global Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 2 Global Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 3 Global Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 4 Cystic Fibrosis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- Table 5 North America: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 6 North America: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 7 North America: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 8 U.S.: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 9 U.S.: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 10 U.S.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 11 Canada: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 12 Canada: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 13 Canada: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 14 Europe: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 15 Europe: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 16 Europe: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 17 UK: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 18 UK: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 19 UK: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 20 France: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 21 France: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 22 France: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 23 Germany: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 24 Germany: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 25 Germany: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 26 Italy: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 27 Italy: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 28 Italy: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 29 Spain: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 30 Spain: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 31 Spain: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 32 Netherlands: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 33 Netherlands: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 34 Netherlands: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 35 Russia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 36 Russia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 37 Russia: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 38 Asia Pacific: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 39 Asia Pacific: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 40 Asia Pacific: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 41 China: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 42 China: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 43 China: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 44 India: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 45 India: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 46 India: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 47 Malaysia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 48 Malaysia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 49 Malaysia: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 50 Japan: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 51 Japan: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 52 Japan: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 53 Indonesia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 54 Indonesia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 55 Indonesia: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 56 South Korea: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 57 South Korea: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 58 South Korea: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 59 Middle East & Africa: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 60 Middle East & Africa: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 61 Middle East & Africa: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 62 Saudi Arabia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 63 Saudi Arabia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 64 Saudi Arabia: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 65 UAE: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 66 UAE: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 67 UAE: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 68 Israel: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 69 Israel: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 70 Israel: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 71 South Africa: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 72 South Africa: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 73 South Africa: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 74 Latin America: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 75 Latin America: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 76 Latin America: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 77 Mexico: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 78 Mexico: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 79 Mexico: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 80 Brazil: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 81 Brazil: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 82 Brazil: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
- Table 83 Argentina: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
- Table 84 Argentina: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- Table 85 Argentina: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
List of Figures
Figure 1. Global Cystic Fibrosis Market, 2018 - 2030 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Route of Administration
Figure 7. Global Cystic Fibrosis Market, by Route of Administration, 2021 & 2030 (USD Billion)
Figure 8. Market by Drug Class
Figure 9. Global Cystic Fibrosis Market, by Drug Class, 2021 & 2030 (USD Billion)
Figure 10. Market by Distribution channel
Figure 11. Global Cystic Fibrosis Market, by Distribution channel, 2021 & 2030 (USD Billion)
Figure 12. Cystic Fibrosis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
Figure 13. Strategic Analysis - Cystic Fibrosis Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.